Las Vegas, NV -- (SBWIRE) -- 09/27/2013 -- Value Stock Pick is a leading Investment Newsletter. Our Research Team conducts research on different stocks, doing their due diligence to provide a detailed report, including both technical and fundamental analysis, on NYSE, NASDAQ, AMEX, OTCBB and Pink Sheet Stocks. Let’s have a brief look at: Baltic Trading Ltd(NYSE:BALT), Omeros Corporation(NASDAQ:OMER), Neuralstem, Inc.(NYSEMKT:CUR), KaloBios Pharmaceuticals Inc(NASDAQ:KBIO
Baltic Trading Ltd(NYSE:BALT)ended higher +1.70% and complete the day at $5.39. The total number of shares changed hands during the day was 1.81m illion. After opening at $5.35, the stock hit as high as $5.54. However, it traded between $2.70 and $5.70 over the last twelve months. Baltic Trading Limited engages in shipping business in the dry bulk industry spot market worldwide.
For How Long BALT will Fight for Profitability? Read This Trend Analysis report
Omeros Corporation(NASDAQ:OMER) closed yesterday at $10.01, a +6.83% increase. Around 1.70 million shares were traded, beating an-average trading volume of 1.27 million shares. The company is now valued at around $298.78 million. Omeros Corporation, a clinical-stage biopharmaceutical company, engages in discovering, developing, and commercializing products targeting inflammation, coagulopathies, and disorders of the central nervous system.
For How Long OMER’s Gloss will Attract Investors? Find out via this report
Neuralstem, Inc.(NYSEMKT:CUR) moved +11.60 percent higher at $2.79 and traded between $2.51 and $2.79 after opening the day at $2.52. Its performance over the last five days remained +2.57%, which stands at +65.09% for a month. Going back further than one month, 1-year performance after recent close was +155.96%. Neuralstem, Inc., a biopharmaceutical company, focuses on the development and commercialization of treatments for central nervous system disease based on human neural stem cells and the use of small molecule compounds.
Will CUR Continue To Move Higher? Find Out Here
KaloBios Pharmaceuticals Inc(NASDAQ:KBIO)’s shares drop, losing -3.89 percent to close at $4.45. The stock is up around -44.37% this year and -44.37% for the last 12 months. Around 1.67 million shares changed hands yesterday, higher from an-average trading volume of 50,676.00 shares. KaloBios Pharmaceuticals, Inc., a biopharmaceutical company, primarily develops monoclonal antibody therapeutics for the treatment of respiratory diseases and cancer in the United States.
Will KBIO Get Buyers Even After The Recent Rally? Find Out Here
About Value Penny Stocks
Value Stock Pick is a leading Investment Newsletter. Our Research Team conducts research on different stocks, doing their due diligence to provide a detailed report, including both technical and fundamental analysis, on NYSE, NASDAQ, AMEX, OTCBB and Pink Sheet Stocks.
PLEASE NOTE WELL: The employees of ValueStockPick.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site, Press releases or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Please Read Our Full Disclaimer at http://www.valuestockpick.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)